The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic and therapeutic impact of cytogenetic abnormalities in patients with myelodysplastic/myeloproliferative neoplasms, unclassifiable.
 
Abhishek Avinash Mangaonkar
No Relationships to Disclose
 
Hassan Alkhateeb
No Relationships to Disclose
 
Aref Al-Kali
Research Funding - Ambit BioSciences (Inst); Astex Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Novartis (Inst); Onconova Therapeutics (Inst)
 
Naseema Gangat
No Relationships to Disclose
 
Kebede Begna
No Relationships to Disclose
 
Michelle A. Elliott
No Relationships to Disclose
 
William J. Hogan
No Relationships to Disclose
 
Darci Zblewski
No Relationships to Disclose
 
Rhett P. Ketterling
No Relationships to Disclose
 
Rebecca L. King
No Relationships to Disclose
 
Mark Robert Litzow
Honoraria - Amgen
Consulting or Advisory Role - Amgen
Research Funding - Actinium Pharmaceuticals; Amgen; Astellas Pharma
Travel, Accommodations, Expenses - Amgen
 
Ayalew Tefferi
No Relationships to Disclose
 
Mrinal Mahesh Patnaik
No Relationships to Disclose